Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00350090
Status:
TERMINATED
Last Update Posted:
2011-05-19
First Post:
2006-07-07
Brief Title:
A Study to Assess the Response Rate of PROCRIT Epoetin Alfa Given at a Dose of 40000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy
Sponsor:
Organization:
Ortho Biotech Products LP
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
98
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: